ORIGINAL RESEARCH

Pathol. Oncol. Res., 29 April 2021
https://doi.org/10.3389/pore.2021.1609761

MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways

www.frontiersin.orgLinlin Wang1,2, www.frontiersin.orgDan Liu1,3,4, www.frontiersin.orgJun Wei1*, www.frontiersin.orgLiwei Yuan1,3, www.frontiersin.orgShiyun Zhao1,3, www.frontiersin.orgYani Huang1,3, www.frontiersin.orgJingwen Ma3 and www.frontiersin.orgZhijuan Yang3
  • 1College of Clinical Medicine, Ningxia Medical University, Yinchuan, China
  • 2Medical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, China
  • 3Department of Gynecology, General Hospital of Ningxia Medical University, Yinchuan, China
  • 4Key Laboratory of Ministry of Education for Fertility Preservation and Maintenance, Ningxia Medical University, Yinchuan, China
This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang L, Liu D, Wei J, Yuan L, Zhao S, Huang Y, Ma J and Yang Z (2021) MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways. Pathol. Oncol. Res. 27:1609761. doi: 10.3389/pore.2021.1609761

Received: 28 January 2021; Accepted: 07 April 2021;
Published: 29 April 2021; Retracted: 25 May 2023.

Edited by:

Anna Sebestyén, Semmelweis University, Hungary